https://www.selleckchem.com/products/lgk-974.html
To determine whether patient-reported health status, more so than comorbidity, influences treatment in men with localized prostate cancer. Using Surveillance, Epidemiology, and End Results data linked with Medicare claims and CAHPS surveys, we identified men aged 65-84 diagnosed with localized prostate cancer from 2004 to 2013 and ascertained their National Cancer Institute (NCI) comorbidity score and patient-reported health status. Adjusting for demographics and cancer risk, we examined the relationship between these measures and treat
Like
Comment
Share
